Navigation Links
Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
Date:3/25/2013

WASHINGTON, March 25, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that the company held a pre-NDA meeting with the Division of Neurology Products of the U.S. Food and Drug Administration (FDA) to discuss the regulatory path for filing a New Drug Application (NDA) for tasimelteon, a circadian regulator, for the treatment of Non-24-Hour Disorder (Non-24).  Non-24 is a serious, rare circadian rhythm disorder that affects a majority of totally blind individuals.  Currently there is no FDA approved treatment for Non-24.

At the pre-NDA meeting, the FDA confirmed that the efficacy and safety data proposed by Vanda to be submitted in the tasimelteon NDA for Non-24 is adequate to support filing.  The NDA supporting package that includes data from clinical pharmacology, pre-clinical pharmacology program, chemistry and manufacturing was also deemed adequate to support filing.

"We are pleased with the positive interaction we had with the FDA as we are moving closer to providing a treatment for blind individuals with Non-24," said Mihael H. Polymeropoulos , M.D., President and CEO of Vanda. 

Based on this successful completion of the pre-NDA meeting, Vanda is targeting an NDA submission for tasimelteon in mid-2013.

About Vanda Pharmaceuticals Inc.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda, please visit www.vandapharma.com.   

Company Contact:
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
2. Vanda Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Results
3. Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary Endpoint
4. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
5. Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on February 12, 2013
6. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
7. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
8. Vanda Pharmaceuticals to Announce Second Quarter 2012 Financial Results on August 2, 2012
9. Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
10. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
11. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Creekridge Capital, an independent vendor-focused ... vendors so far in 2014 to their portfolio ... are from both the healthcare and technology industries. ... well-known multi-national companies. Each of these new vendors ... products including: standard leasing products, subscription solutions, a ...
(Date:7/23/2014)... YORK , July 23, 2014 ... Beach, Fla. , is an emerging player ... diagnostic systems for bio-threat detection and rapid medical ... called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was ... Homeland Security ("DHS") Science & Technology directorate, and ...
(Date:7/23/2014)... MEETING, Pa. , July 23, 2014 ... INO) today announced successful results from its ... VGX-3100 in women with biopsy-proven cervical intraepithelial ... (HPV) types 16 or 18. Treatment with ... regression of CIN2/3 to CIN1 or no ...
Breaking Medicine Technology:Creekridge Capital Signs Several New Vendor Partners 2PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 2Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 3Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 4Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial 5
(Date:7/23/2014)... News) -- Painful or itchy skin lesions could be ... "Patients sometimes have multiple lesions that are suspicious looking, ... high concerns for non-melanoma skin cancers," study author Dr. ... of Medicine, said in a Temple University Health System ... of 268 patients who were confirmed to have skin ...
(Date:7/23/2014)... Agricultural and Forestry University in Shaanxi province, and the ... agreement that lays the groundwork for establishing the Sino-U.S. ... The signing ceremony was held in the city of ... the U.S. Department of Agriculture and China,s Ministry of ... event for UC Davis and for our World Food ...
(Date:7/23/2014)... 2014 The American Telemedicine Association ... twentieth annual meeting and tradeshow focused exclusively on ... attract over 5,000 attendees and more than 250 ... 3-5, 2015, in Los Angeles. , ATA’s annual ... professionals from researchers, clinicians, hospital and university administrators, ...
(Date:7/23/2014)... 23, 2014 Bodybuilding.com, the Internet’s most-visited ... of nutritional supplements, has officially opened the polls for ... , the fastest growing sports nutrition company, is up ... of the Year, Best Tasting Protein of the Year- ... of the year - Whey-HD™, Pre-workout Supplement of the ...
(Date:7/23/2014)... The voice on the recording was low and calm as the ... infected with the human immunodeficiency virus (HIV) that causes AIDS: “My ... know I was on the floor flat on my face boohooing, ... the recording ended less than 10 minutes later. “Don’t feel like ... it is just God setting you up for something greater,” the ...
Breaking Medicine News(10 mins):Health News:Painful, Itchy Patches Could Be Sign of Skin Cancer 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3
... , Transplant surgeons at Johns Hopkins who have reviewed the ... that it is not simply racial differences, but rather flaws ... and education levels, in addition to biological factors, that are ... in African Americans. In a report on the review ...
... ... compensation costs , ... Oak Brook, IL (Vocus) May 31, 2010 -- AthletiCo Physical and Occupational Therapy ... OTR/L, to manage its Ergonomics and Job Analysis Program. Harris’s role as the ...
... urological problems, studies show , MONDAY, May 31 (HealthDay ... start exercising and steer clear of smoking, new research ... urinary health in women and sexual health in men. ... Finnish women, aged 18 to 79, about smoking and ...
... Medical Association Journal ) found a 68% increase in the ... link only) http://www.cmaj.ca/embargo/cmaj091208.pdf . Antidepressants are widely ... use them at some point during the first trimester. Discontinuing ... mother and baby at risk. Most previous studies ...
... illnesses kill more females than males, organizers say ... cancer death rates for women are generally on ... fatalities are rising, the American Lung Association (ALA) ... every year from tobacco-related illness, the ALA estimates. ...
... ... ... Those seeking to obtain ultimate health should take a page from author Fay Julius-Williams’ book, ... previous years and now walking in health, the author penned the new title in order ...
Cached Medicine News:Health News:Lack of private insurance contribute to higher deaths among black heart transplant patients 2Health News:Lack of private insurance contribute to higher deaths among black heart transplant patients 3Health News:Lack of private insurance contribute to higher deaths among black heart transplant patients 4Health News:AthletiCo Physical Therapy Enhances Work Rehabilitation Program by Offering Ergonomics and Job Analysis 2Health News:AthletiCo Physical Therapy Enhances Work Rehabilitation Program by Offering Ergonomics and Job Analysis 3Health News:Antidepressants in pregnancy increase risk of miscarriage 2Health News:Women Smokers Targeted on 'World No Tobacco Day' 2Health News:Obtain Ultimate Health from Tips in New Xulon Press Title 2
Small curved rounded blade. Flat serrated handle with polished finish....
For use with E0828 needle and gouge set and E0828 C handle. Triangular shape curved 5.0 mm blade. Polished finish. Most popular size or model....
Set consists of one each:E0824 A replacement burr set. E0824 B handle....
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle....
Medicine Products: